NCT02894879

Brief Summary

The purpose of this study is to explore effectiveness of modified chest physical therapy techniques using new device in pre and post-operative program in patients undergoing open heart surgery

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2016

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 15, 2016

Completed
17 days until next milestone

Study Start

First participant enrolled

September 1, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 9, 2016

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2017

Completed
Last Updated

October 14, 2016

Status Verified

October 1, 2016

Enrollment Period

7 months

First QC Date

August 15, 2016

Last Update Submit

October 13, 2016

Conditions

Keywords

Postoperative pulmonary complications

Outcome Measures

Primary Outcomes (2)

  • Incidence of PPCs,

    Incidence of PPCs were recorded from atelectasis, pneumonia, and pleural effusion according to clinical (symptoms and examinations) and radiological criteria in postoperative day 1-5 and diagnosed by the physician.

    postoperative day 1-5

  • The duration of breathing with a mode of mechanical ventilator and duration of intubation time

    Duration of mode of mechanical ventilation and intubation times. Dependent variables, mode and duration of mechanical ventilation, starting records mode of mechanical ventilator when the patients arrive to ICU until extubation

    postoperative 4 weeks

Secondary Outcomes (2)

  • length of ICU and hospital stay

    postoperative 4 weeks

  • Pulmonary function test

    pre-operation and post-operative 1-5 days

Study Arms (2)

Modify group

EXPERIMENTAL

For 2 days pre-surgery and continuous post-surgery repeated for 5 sets a day. The patients in Modify group will be taught 4 modify techniques and receive cardiac rehabilitation phase 1 in postoperative period.

Device: BreatheMAX®

Conventional group

SHAM COMPARATOR

For 2 days pre-surgery and continuous post-surgery repeated for 5 sets a day. The patients in Modify group will be taught 3 conventional techniques and receive cardiac rehabilitation phase 1 in postoperative period.

Other: Routine treatment

Interventions

Modify chest physical therapy * oscillated incentive spirometry (OIS) with inspiratory load of 5-8 cm H2O 30 times/set * oscillated positive expiratory pressure (OPEP) with expiratory load of 5-8 cm H2O 30 times/set * Coughing with splinting 3 times/set * Chest mobilization with overhead both arms rises 10 times/set total 5 set/day

Modify group

Routine chest physical therapy * Deep breathing exercise (upper and lower costal and diaphragmatic breathing exercise) as deep as possible for 10 times/set/level * Coughing with splinting 3 times/set * Chest mobilization with overhead both arms raised 10 times/set total 5 set/day

Conventional group

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with a leaky septal defect, valvular heart disease and coronary artery disease, both male, and female, scheduled for primary elective open heart surgery age 20-80 years who had the ability to communicate and understand informed consent.

You may not qualify if:

  • Unstable angina pectoris at the moment of selection or during the program
  • Complex ventricular and uncontrolled arrhythmia
  • Uncontrolled high blood pressure (\> 140/90 mm/Hg)
  • A history of cerebrovascular accident
  • Presence of a neuromuscular disorder
  • Cardiovascular instability or the existence an aneurysm
  • Ejection fractions were less than 0.40
  • Unable to participate because of physical limitations

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Khon Kaen hospital

Maung Khon Kaen, KhonKaen, 40000, Thailand

RECRUITING

Study Officials

  • Atidtaya yotwong, master

    Khon Kaen University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Atidtaya yotwong, master

CONTACT

Chulee Jones, doctor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 15, 2016

First Posted

September 9, 2016

Study Start

September 1, 2016

Primary Completion

April 1, 2017

Study Completion

April 1, 2017

Last Updated

October 14, 2016

Record last verified: 2016-10

Locations